Himalaya Nutravedics India Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹0(0.00%)
Premium (ELP)
Himalaya Nutravedics India Limited's is preparing to launch its Initial Public Offering (IPO) with a substantial issue size of 25,00,000 Shares. The offering comprises a fresh issue component of 25,00,000 Shares.
The price band for the IPO has been set at TBD, providing investors with a range to place their bids. The minimum investment lot consists of TBD, making it accessible to both retail and institutional investors.
The subscription window for this public offering opens on TBD and will conclude on TBD. Following the subscription period, the share allotment is scheduled for TBD, with the official listing expected to commence on TBD on the BSE exchange.
Himalaya Nutravedics India Ltd is engaged in the manufacturing, marketing, and distribution of Ayurvedic and nutraceutical formulations in India, along with offering third-party contract manufacturing services for other companies in this space. The company has a diversified product portfolio comprising classical Ayurvedic formulations based on traditional texts, proprietary Ayurvedic products, and nutraceutical supplements, available in various dosage forms such as soft gelatin capsules, hard gelatin capsules, tablets, liquid orals, and medicated oils. It operates on a hybrid business model that balances its own branded products with contract manufacturing, supported by an integrated in-house manufacturing facility located in Hyderabad, Telangana. As of September 2025, its products are distributed across multiple states including Telangana, Andhra Pradesh, Kerala, Gujarat, and Uttar Pradesh, with offerings catering to a wide range of wellness segments such as digestive health, immunity, metabolic health, joint care, reproductive health, respiratory wellness, pain management, and overall well-being, aligned with regulatory standards.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
The expected premium is based on market buzz and online information. It should not be considered as the actual listing price or valuation. Always refer to the RHP and seek advice from a financial expert before making any investment decisions.
- Healthcare & Wellness Focus: Operates in pharma and nutraceuticals, a sector with growing demand for health products.
- Growth Potential: Early-stage presence in an expanding industry allows opportunities for business and market expansion.
- Structured Setup: Increasing capital and formal organization support planned growth and operations.
- Short Operating History: Being a new company, it has limited experience and track record.
- Limited Financial Data: Revenue and profitability details are minimal, making evaluation difficult.
- Debt Exposure: Existing borrowings or financial obligations could impact cash flow and stability.
- Rohit Asawa
- Divya Asawa
- Chanda Asawa
- Rama Raju
Himalaya Nutravedics India Limited
Kfin Technologies Limited